Literature DB >> 27069334

Serum Lactate Dehydrogenase in Non-Hodgkin's Lymphoma: A Prognostic Indicator.

Charu Yadav1, Afzal Ahmad1, Benedicta D'Souza1, Ashish Agarwal1, M Nandini1, K Ashok Prabhu1, Vivian D'Souza2.   

Abstract

Non-Hodgkin's lymphoma constitutes a group of disorders originating from the malignant transformation of lymphocytes and involving either the lymph nodes or extranodal sites. NHL commonly presents in the sixth to seventh decade of life with a male preponderance (50-75 %). Recent studies have shown importance of serum LDH in prognosis of NHL. Authors report a case of a 63 year old male presenting with complaints of fever and backache for past 4 months. General and systemic examination revealed bilateral axillary lymphadenopathy and splenomegaly respectively. Serum LDH level was highly elevated (3441 U/l). Excisional axillary and bone marrow biopsy were done before oncology referral. Complete workup revealed diffuse Non-Hodgkin's lymphoma with bone marrow infiltration. Patient died because of acute renal failure due to NHL and DM 2 (Type 2 diabetes mellitus).

Entities:  

Keywords:  Lactate dehydrogenase (LDH); Non-Hodgkin’s lymphoma (NHL)

Year:  2015        PMID: 27069334      PMCID: PMC4820421          DOI: 10.1007/s12291-015-0511-3

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  9 in total

1.  Elevated serum LDH in patients with non-Hodgkin's lymphoma: not always an ominous sign.

Authors:  D P Steensma; T E Witzig
Journal:  Br J Haematol       Date:  1999-11       Impact factor: 6.998

2.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

3.  Non-Hodgkin's lymphoma: is India ready to incorporate recent advances in day to day practice?

Authors:  Saraschandra Vallabhajosyula; Gunjan Baijal; B M Vadhiraja; Donald J Fernandes; M S Vidyasagar
Journal:  J Cancer Res Ther       Date:  2010 Jan-Mar       Impact factor: 1.805

Review 4.  Onco-nephrology: AKI in the cancer patient.

Authors:  Albert Q Lam; Benjamin D Humphreys
Journal:  Clin J Am Soc Nephrol       Date:  2012-08-09       Impact factor: 8.237

Review 5.  Lactate dehydrogenase 5: an old friend and a new hope in the war on cancer.

Authors:  Katarzyna Augoff; Anita Hryniewicz-Jankowska; Renata Tabola
Journal:  Cancer Lett       Date:  2014-12-17       Impact factor: 8.679

6.  Lymphoma: diagnosis, staging, natural history, and treatment strategies.

Authors:  Pier Luigi Zinzani
Journal:  Semin Oncol       Date:  2005-02       Impact factor: 4.929

7.  Subclassification of diffuse large B-cell lymphomas according to the Kiel classification: distinction of centroblastic and immunoblastic lymphomas is a significant prognostic risk factor.

Authors:  M Engelhard; G Brittinger; D Huhn; H H Gerhartz; P Meusers; W Siegert; E Thiel; W Wilmanns; U Aydemir; S Bierwolf; H Griesser; M Tiemann; K Lennert
Journal:  Blood       Date:  1997-04-01       Impact factor: 22.113

8.  Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features.

Authors:  G Fasola; R Fanin; F Gherlinzoni; P Galieni; D Taruscio; G Frezza; P Mazza; S Pileri; M Baccarani
Journal:  Acta Haematol       Date:  1984       Impact factor: 2.195

9.  Prognostic factors in high and intermediate grade non-Hodgkin's lymphoma.

Authors:  R A Cowan; M Jones; M Harris; W P Steward; J A Radford; J Wagstaff; D P Deakin; D Crowther
Journal:  Br J Cancer       Date:  1989-02       Impact factor: 7.640

  9 in total
  6 in total

Review 1.  Non-Hodgkin Lymphoma Metabolism.

Authors:  Brian James Kirsch; Shu-Jyuan Chang; Anne Le
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

2.  Clinical and immunophenotypic findings in 4 forms of equine lymphoma.

Authors:  Arianna Miglio; Chiara Morelli; Rodolfo Gialletti; Eleonora Lauteri; Monica Sforna; Maria Luisa Marenzoni; Maria Teresa Antognoni
Journal:  Can Vet J       Date:  2019-01       Impact factor: 1.008

3.  Non-Hodgkin Lymphoma Metabolism.

Authors:  Brian James Kirsch; Shu-Jyuan Chang; Michael James Betenbaugh; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  Single Nucleotide Polymorphisms in MIR143 Contribute to Protection Against Non-Hodgkin Lymphoma (NHL) in Caucasian Populations.

Authors:  Gabrielle Bradshaw; Larisa M Haupt; Eunise M Aquino; Rodney A Lea; Heidi G Sutherland; Lyn R Griffiths
Journal:  Genes (Basel)       Date:  2019-02-27       Impact factor: 4.096

Review 5.  Metabolic Biomarkers in B-Cell Lymphomas for Early Diagnosis and Prediction, as Well as Their Influence on Prognosis and Treatment.

Authors:  Abdullah Alfaifi; Salem Bahashwan; Mohammed Alsaadi; Hafiz Malhan; Aqeel Aqeel; Waiel Al-Kahiry; Hussein Almehdar; Ishtiaq Qadri
Journal:  Diagnostics (Basel)       Date:  2022-02-03

6.  The Endothelial Activation and Stress Index (EASIX) score is an independent prognostic factor in patients with diffuse large B-cell lymphoma.

Authors:  Sungwoo Park; Se-Il Go; Gyeong-Won Lee
Journal:  BMC Cancer       Date:  2022-07-25       Impact factor: 4.638

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.